Biohit Oyj - Managers' transactions

Biohit Oyj - Managers' Transactions

Biohit Oyj - Managers' Transactions, March 3, 2017 at 11:05 am local time (EET)



Person subject to the notification requirement                                  
Name:                           Hendolin, Panu                                  
Position:                       Other senior manager                            
                                                                                
--------------------------------------------------------------------------------
Initial Notification                                                            
Reference number:               74370089ATTSNBXJVT29_20170302112710_1           
                                                                                
--------------------------------------------------------------------------------
Issuer                                                                          
Name:                           Biohit Oyj                                      
LEI:                            74370089ATTSNBXJVT29                            
                                                                                
--------------------------------------------------------------------------------
Transaction details                                                             
Transaction date:               2017-03-01                                      
Venue:                          NASDAQ HELSINKI LTD (XHEL)                      
Nature of the transaction:      Exercise (Rights, Put and Call Options)         
Further details:                                                                
                                Linked to stock option programme                
                                                                                
Instrument:                     Financial Instrument Linked to a Share or a Debt
                                 Instrument                                     
ISIN:                           FI4000219324                                    
                                                                                
Volume:                         2102                                            
Unit price:                     3,04340 Euro                                    
                                                                                
Aggregated transactions                                                         
Volume:                         2102                                            
Volume weighted average price:  3.04340 Euro                                    
                                                                                
--------------------------------------------------------------------------------
Transaction details                                                             
Transaction date:               2017-03-01                                      
Venue:                          NASDAQ HELSINKI LTD (XHEL)                      
Nature of the transaction:      Subscription                                    
Further details:                                                                
                                Linked to stock option programme                
                                                                                
Instrument:                     Financial Instrument Linked to a Share or a Debt
                                 Instrument                                     
ISIN:                           FI4000219324                                    
                                                                                
Volume:                         774                                             
Unit price:                     2,27660 Euro                                    
                                                                                
Aggregated transactions                                                         
Volume:                         774                                             
Volume weighted average price:  2.27660 Euro                                    
                                                                                
--------------------------------------------------------------------------------
Transaction details                                                             
Transaction date:               2017-03-01                                      
Venue:                          NASDAQ HELSINKI LTD (XHEL)                      
Nature of the transaction:      Disposal                                        
Further details:                                                                
                                Linked to stock option programme                
                                                                                
Instrument:                     Financial Instrument Linked to a Share or a Debt
                                 Instrument                                     
ISIN:                           FI4000219324                                    
                                                                                
Volume:                         774                                             
Unit price:                     0,00000 Euro                                    
                                                                                
Aggregated transactions                                                         
Volume:                         774                                             
Volume weighted average price:  0.00000 Euro                                    



Additional information:
CEO Semi Korpela, Biohit Oyj
tel. +358 9 773 861
investor.relations@biohit.fi
www.biohithealthcare.com


Biohit in brief

Biohit Oyj is a globally operating Finnish biotechnology company. Biohit’s
mission is “Innovating for Health” – we produce innovative products and
services to promote research and early diagnosis. Biohit is headquartered in
Helsinki, Finland, and has subsidiaries in Italy and the UK. Biohit's Series B
share (BIOBV) is quoted on Nasdaq Helsinki in the Small cap/Healthcare group.
www.biohithealthcare.com